Resilience in women with primary Sjögren’s syndrome

被引:0
|
作者
Roberta Priori
Federico Giardina
Raffaella Izzo
Angelica Gattamelata
Massimo Fusconi
Serena Colafrancesco
Giuseppe Curcio
机构
[1] Azienda Ospedaliera Universitaria Policlinico Umberto I,Department of Clinical, Internal, Anesthetic and Cardiovascular Science
[2] Sapienza University of Rome,Rheumatology Unit
[3] Sapienza University of Rome,Department of Oral and Maxillo
[4] University of L’Aquila,Facial Surgery
[5] UniCamillus,Department of Biotechnological and Applied Clinical Sciences
[6] Saint Camillus International University of Health Sciences,undefined
来源
关键词
Sjögren’s syndrome; Mood disorders; Fatigue Assessment Scale (FAS); Resilience;
D O I
暂无
中图分类号
学科分类号
摘要
To assess the relationship between resilience and several diseases and individual features in primary Sjӧgren's Syndrome (SS) patients. Resilience was assessed using the Resilience Scale (RS-14). Disease activity, damage, and reported symptoms were assessed by means of ESSDAI (EULAR Sjögren's syndrome disease activity index), SSDDI (Sjӧgren's Syndrome Disease Damage Index) and ESSPRI (EULAR Sjӧgren's Syndrome Patient Reported Index). EuroQol, HADS (Hospital Anxiety and Depression Scale), SF-12 (Short-form 12 health survey), FAS (Fatigue Assessment Scale), FACIT-F (Functional Assessment of Chronic Illness Therapy – Fatigue), and IPAQ (International Physical Activity Questionnaire) questionnaires were submitted to evaluate physical and mental well-being of the recruited patients. Data about the autoimmune profile, systemic manifestations, and current therapy were collected. Educational qualifications and work activities were also considered. Descriptive, correlational, and linear regression analysis were performed. 74 consecutive women with primary SS and 74 sex and age-matched healthy subjects as a control group were recruited. SS patients displayed a moderate value of resilience (median 78.5) with no significant difference compared to controls (p = 0.38). An inverse relationship was found between resilience and mood disorders such as anxiety (p = 0.038) and depression (p < 0.001). Greater resilience was associated with a better perception of the quality of life (p = 0.02) and general health (p < 0.001), as well as with less fatigue (p = 0.008) and a more physically active lifestyle (p = 0.001). No significant relationship was found neither between resilience and age, socio-demographic and disease characteristics, nor with ESSDAI (p = 0.26), ESSPRI (p = 0.83) and SSDDI (p = 0.67). This is the first study assessing resilience in a large group of unselected primary SS patients. Most resilient primary SS patients are less depressed and show a better perception of their health. Greater resilience tends to correlate with less anxiety, physical and mental fatigue, and a more active lifestyle, while no association with disease activity and duration, damage, and socio-demographic features was detected. Considering the well-known role of resilience in helping to better cope with chronic illnesses, its assessment in SS patients should not be overlooked and the possible strategies for its improvement should be better explored and further implemented.
引用
收藏
页码:1987 / 1994
页数:7
相关论文
共 50 条
  • [41] Pulmonary and thymic lymphoid hyperplasia in primary Sjögren’s syndrome
    Hideo Kobayashi
    Yuichi Ozeki
    Shinsuke Aida
    Japanese Journal of Radiology, 2009, 27
  • [42] Identification and verification of inflammatory biomarkers for primary Sjögren’s syndrome
    Xiaodan Liu
    Haojie Wang
    Xiao Wang
    Xiaodan Jiang
    Yinji Jin
    Ying Han
    Zhihui Zhang
    Clinical Rheumatology, 2024, 43 : 1335 - 1352
  • [43] IkBα Promoter Polymorphisms in Patients with Primary Sjögren’s Syndrome
    Tsan-Teng Ou
    Chia-Hui Lin
    Yu-Chih Lin
    Ruei-Nian Li
    Wen-Chan Tsai
    Hong-Wen Liu
    Jeng-Hsien Yen
    Journal of Clinical Immunology, 2008, 28 : 440 - 444
  • [44] Altered expression of circular RNA in primary Sjögren’s syndrome
    Lin-Chong Su
    Wang-Dong Xu
    Xiao-Yan Liu
    Lu Fu
    An-Fang Huang
    Clinical Rheumatology, 2019, 38 : 3425 - 3433
  • [45] Epratuzumab shows promise in the treatment of primary Sjögren's syndrome
    Nature Clinical Practice Rheumatology, 2006, 2 (11): : 583 - 583
  • [47] Characteristics of the oral microbiota in patients with primary Sjögren's syndrome
    Xie, Yiwen
    Fan, Yu
    Su, Miaotong
    Wang, Yukai
    Zhang, Guohong
    CLINICAL RHEUMATOLOGY, 2024, 43 (06) : 1939 - 1947
  • [48] Adrenomedullary Response to Glucagon in Patients with Primary Sjögren’s Syndrome
    Richard Imrich
    Nikolay P. Nikolov
    Lolita Bebris
    Ilias Alevizos
    David S. Goldstein
    Courtney S. Holmes
    Gabor G. Illei
    Cellular and Molecular Neurobiology, 2012, 32 : 903 - 906
  • [49] Clinical manifestations of neurological involvement in primary Sjögren’s syndrome
    Takahisa Gono
    Yasushi Kawaguchi
    Yasuhiro Katsumata
    Kae Takagi
    Akiko Tochimoto
    Sayumi Baba
    Yuko Okamoto
    Yuko Ota
    Hisashi Yamanaka
    Clinical Rheumatology, 2011, 30 : 485 - 490
  • [50] Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: A preliminary study
    Streckfus C.
    Bigler L.
    Navazesh M.
    Al-Hashimi I.
    Clinical Oral Investigations, 2001, 5 (2) : 133 - 135